Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ACADIAN DIAGNOSTIC LABORATORIES LLC

NPI: 1316370950 · BATON ROUGE, LA 70816 · Clinical Medical Laboratory · NPI assigned 08/19/2013

$6.81M
Total Medicaid Paid
507,282
Total Claims
245,409
Beneficiaries
138
Codes Billed
2018-01
First Month
2021-04
Last Month

Provider Details

Authorized OfficialWILKS, TERRY (CEO/OWNER)
NPI Enumeration Date08/19/2013

Related Entities

Other providers sharing the same authorized official: WILKS, TERRY

ProviderCityStateTotal Paid
EVANGELINE DIAGNOSTIC CENTER LLC VILLE PLATTE LA $2.85M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 288,463 $3.60M
2019 217,831 $3.17M
2020 646 $27K
2021 342 $8K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 18,017 13,338 $1.65M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 6,808 3,089 $405K
80336 14,477 6,354 $174K
80372 15,352 6,670 $169K
80367 15,327 6,658 $169K
80373 15,314 6,665 $169K
80366 15,231 6,599 $163K
80357 14,891 6,359 $163K
80368 15,227 6,567 $163K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 4,522 2,048 $159K
80346 15,393 6,684 $157K
80361 15,343 6,681 $148K
80354 15,392 6,702 $148K
80356 15,344 6,674 $148K
80339 14,984 6,361 $147K
80348 14,727 6,334 $146K
80365 15,282 6,632 $145K
80360 14,944 6,289 $141K
80358 15,364 6,683 $141K
80323 12,209 5,143 $140K
80371 14,857 6,257 $140K
80364 14,233 6,224 $139K
80349 14,747 6,370 $139K
80369 11,371 4,794 $135K
80359 15,264 6,583 $133K
80350 14,260 6,171 $130K
80338 11,235 4,576 $130K
80353 15,159 6,609 $129K
83992 13,698 6,588 $127K
80324 11,867 4,950 $124K
80355 14,092 6,216 $110K
80321 13,517 6,176 $105K
80370 3,819 1,905 $37K
80332 3,232 1,617 $30K
81403 393 346 $22K
81405 396 345 $22K
81404 394 343 $19K
81211 264 237 $18K
81201 400 347 $15K
81317 395 347 $14K
81298 394 346 $14K
81288 396 348 $14K
81295 394 346 $13K
80325 3,670 1,788 $11K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 123 93 $11K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 578 362 $10K
81325 211 195 $9K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,899 1,680 $9K
80050 General health panel 400 360 $9K
81259 213 197 $9K
81242 211 195 $8K
84403 1,107 930 $8K
82670 987 834 $7K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 85 82 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,167 999 $6K
80061 Lipid panel 1,691 1,453 $5K
84270 988 834 $5K
80053 Comprehensive metabolic panel 1,801 1,609 $5K
80335 705 322 $5K
80347 663 302 $5K
82607 1,225 1,052 $5K
84144 912 767 $4K
80362 694 311 $4K
82627 872 732 $4K
83001 922 776 $4K
84146 871 733 $4K
83002 875 737 $4K
84681 853 722 $4K
83036 Hemoglobin; glycosylated (A1C) 1,829 1,591 $3K
82533 877 728 $3K
84443 Thyroid stimulating hormone (TSH) 1,420 1,221 $3K
82746 843 702 $3K
84481 975 813 $3K
82728 1,072 911 $3K
83003 789 669 $3K
83525 900 758 $2K
80363 200 178 $2K
82172 847 672 $2K
84439 1,108 924 $2K
83735 1,112 940 $1K
83695 876 722 $1K
84153 320 280 $1K
82150 912 747 $1K
83540 784 639 $1K
83550 657 558 $1K
84550 895 739 $1K
82977 633 496 $1K
86140 1,007 836 $1K
84402 229 197 $991.91
84702 311 278 $915.50
84100 920 779 $841.77
82248 696 576 $718.67
86592 243 218 $558.89
87086 Culture, bacterial; quantitative colony count, urine 308 276 $535.18
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 188 169 $485.58
81328 58 39 $483.35
81230 57 40 $483.35
81231 60 41 $483.35
83937 67 63 $445.65
80374 125 92 $445.50
85027 47 42 $352.98
81003 277 245 $297.04
81025 122 100 $281.64
81241 58 39 $273.64
81001 260 240 $269.36
83090 244 224 $247.81
81479 Unlisted molecular pathology procedure 59 41 $195.75
80048 Basic metabolic panel (calcium, ionized) 180 166 $187.03
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 19 19 $182.39
81240 58 39 $181.59
80076 175 160 $180.10
81291 58 39 $150.36
81227 61 42 $141.71
86900 177 160 $124.99
85651 70 66 $119.74
80334 13 13 $115.50
87631 14 12 $114.10
87340 146 132 $90.56
81355 58 39 $79.03
86762 142 129 $78.64
87634 14 12 $57.28
82043 34 32 $42.89
86850 159 141 $30.51
85007 41 38 $27.03
86901 173 158 $22.21
82947 76 52 $16.78
82950 14 13 $5.84
81401 57 39 $0.00
0032U 17 17 $0.00
80164 13 12 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 48 42 $0.00
81225 61 42 $0.00
81226 61 42 $0.00
86701 17 13 $0.00
84479 67 63 $0.00
84436 106 102 $0.00
84480 103 99 $0.00
0031U 17 17 $0.00